nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbinoxamine—CYP2C19—epilepsy syndrome	0.113	0.574	CbGaD
Carbinoxamine—CYP2D6—epilepsy syndrome	0.084	0.426	CbGaD
Carbinoxamine—Chlorcyclizine—Clobazam—epilepsy syndrome	0.0419	0.178	CrCrCtD
Carbinoxamine—Clomipramine—Clobazam—epilepsy syndrome	0.0352	0.149	CrCrCtD
Carbinoxamine—Chlorprothixene—Midazolam—epilepsy syndrome	0.0345	0.146	CrCrCtD
Carbinoxamine—Clomipramine—Diazepam—epilepsy syndrome	0.0327	0.139	CrCrCtD
Carbinoxamine—Chlorpromazine—Clobazam—epilepsy syndrome	0.0311	0.132	CrCrCtD
Carbinoxamine—Chlorprothixene—Diazepam—epilepsy syndrome	0.0307	0.13	CrCrCtD
Carbinoxamine—Diphenhydramine—Phenytoin—epilepsy syndrome	0.0295	0.125	CrCrCtD
Carbinoxamine—CYP2E1—Felbamate—epilepsy syndrome	0.0145	0.0341	CbGbCtD
Carbinoxamine—CYP2E1—Trimethadione—epilepsy syndrome	0.0145	0.0341	CbGbCtD
Carbinoxamine—CYP2B6—Fosphenytoin—epilepsy syndrome	0.0135	0.0317	CbGbCtD
Carbinoxamine—CYP2E1—Clonazepam—epilepsy syndrome	0.0124	0.029	CbGbCtD
Carbinoxamine—CYP2B6—Clobazam—epilepsy syndrome	0.0117	0.0275	CbGbCtD
Carbinoxamine—CYP2C8—Trimethadione—epilepsy syndrome	0.0109	0.0255	CbGbCtD
Carbinoxamine—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0102	0.024	CbGbCtD
Carbinoxamine—CYP2E1—Rufinamide—epilepsy syndrome	0.0101	0.0237	CbGbCtD
Carbinoxamine—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00981	0.023	CbGbCtD
Carbinoxamine—CYP2B6—Carbamazepine—epilepsy syndrome	0.00969	0.0228	CbGbCtD
Carbinoxamine—CYP2C19—Felbamate—epilepsy syndrome	0.00912	0.0214	CbGbCtD
Carbinoxamine—CYP2C19—Trimethadione—epilepsy syndrome	0.00912	0.0214	CbGbCtD
Carbinoxamine—CYP2B6—Primidone—epilepsy syndrome	0.00905	0.0212	CbGbCtD
Carbinoxamine—CYP2B6—Phenytoin—epilepsy syndrome	0.0087	0.0204	CbGbCtD
Carbinoxamine—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00857	0.0201	CbGbCtD
Carbinoxamine—CYP2E1—Propofol—epilepsy syndrome	0.00822	0.0193	CbGbCtD
Carbinoxamine—CYP2B6—Propofol—epilepsy syndrome	0.00811	0.019	CbGbCtD
Carbinoxamine—CYP2E1—Phenobarbital—epilepsy syndrome	0.00786	0.0184	CbGbCtD
Carbinoxamine—CYP2B6—Phenobarbital—epilepsy syndrome	0.00775	0.0182	CbGbCtD
Carbinoxamine—CYP2E1—Midazolam—epilepsy syndrome	0.00775	0.0182	CbGbCtD
Carbinoxamine—CYP2B6—Midazolam—epilepsy syndrome	0.00764	0.0179	CbGbCtD
Carbinoxamine—CYP2C9—Trimethadione—epilepsy syndrome	0.00758	0.0178	CbGbCtD
Carbinoxamine—CYP2E1—Diazepam—epilepsy syndrome	0.00745	0.0175	CbGbCtD
Carbinoxamine—CYP2C19—Clobazam—epilepsy syndrome	0.00743	0.0174	CbGbCtD
Carbinoxamine—CYP2B6—Diazepam—epilepsy syndrome	0.00735	0.0172	CbGbCtD
Carbinoxamine—CYP2C8—Carbamazepine—epilepsy syndrome	0.00734	0.0172	CbGbCtD
Carbinoxamine—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00713	0.0167	CbGbCtD
Carbinoxamine—CYP2C8—Primidone—epilepsy syndrome	0.00685	0.0161	CbGbCtD
Carbinoxamine—CYP2C8—Phenytoin—epilepsy syndrome	0.00659	0.0155	CbGbCtD
Carbinoxamine—CYP2C19—Carbamazepine—epilepsy syndrome	0.00616	0.0145	CbGbCtD
Carbinoxamine—CYP2C8—Propofol—epilepsy syndrome	0.00614	0.0144	CbGbCtD
Carbinoxamine—CYP2C8—Phenobarbital—epilepsy syndrome	0.00587	0.0138	CbGbCtD
Carbinoxamine—CYP2B6—Valproic Acid—epilepsy syndrome	0.00579	0.0136	CbGbCtD
Carbinoxamine—CYP2C19—Primidone—epilepsy syndrome	0.00575	0.0135	CbGbCtD
Carbinoxamine—CYP2C8—Diazepam—epilepsy syndrome	0.00556	0.0131	CbGbCtD
Carbinoxamine—CYP2C19—Phenytoin—epilepsy syndrome	0.00553	0.013	CbGbCtD
Carbinoxamine—CYP2C19—Propofol—epilepsy syndrome	0.00515	0.0121	CbGbCtD
Carbinoxamine—CYP2C9—Carbamazepine—epilepsy syndrome	0.00512	0.012	CbGbCtD
Carbinoxamine—CYP2C19—Phenobarbital—epilepsy syndrome	0.00492	0.0116	CbGbCtD
Carbinoxamine—CYP2C9—Primidone—epilepsy syndrome	0.00478	0.0112	CbGbCtD
Carbinoxamine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00474	0.0111	CbGbCtD
Carbinoxamine—CYP2C19—Diazepam—epilepsy syndrome	0.00467	0.011	CbGbCtD
Carbinoxamine—CYP2C9—Phenytoin—epilepsy syndrome	0.00459	0.0108	CbGbCtD
Carbinoxamine—CYP2C19—Zonisamide—epilepsy syndrome	0.00456	0.0107	CbGbCtD
Carbinoxamine—CYP3A4—Felbamate—epilepsy syndrome	0.00441	0.0103	CbGbCtD
Carbinoxamine—CYP3A4—Trimethadione—epilepsy syndrome	0.00441	0.0103	CbGbCtD
Carbinoxamine—CYP2C8—Valproic Acid—epilepsy syndrome	0.00439	0.0103	CbGbCtD
Carbinoxamine—CYP2C9—Propofol—epilepsy syndrome	0.00428	0.0101	CbGbCtD
Carbinoxamine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00414	0.00973	CbGbCtD
Carbinoxamine—CYP2C9—Phenobarbital—epilepsy syndrome	0.00409	0.00961	CbGbCtD
Carbinoxamine—CYP2D6—Propofol—epilepsy syndrome	0.00392	0.00919	CbGbCtD
Carbinoxamine—CYP2C9—Diazepam—epilepsy syndrome	0.00388	0.00911	CbGbCtD
Carbinoxamine—CYP3A4—Clonazepam—epilepsy syndrome	0.00375	0.0088	CbGbCtD
Carbinoxamine—CYP2C19—Valproic Acid—epilepsy syndrome	0.00368	0.00864	CbGbCtD
Carbinoxamine—CYP3A4—Clobazam—epilepsy syndrome	0.00359	0.00843	CbGbCtD
Carbinoxamine—CYP2C19—Topiramate—epilepsy syndrome	0.00332	0.00779	CbGbCtD
Carbinoxamine—CYP2C9—Valproic Acid—epilepsy syndrome	0.00306	0.00718	CbGbCtD
Carbinoxamine—CYP3A4—Rufinamide—epilepsy syndrome	0.00306	0.00717	CbGbCtD
Carbinoxamine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00298	0.00699	CbGbCtD
Carbinoxamine—CYP3A4—Primidone—epilepsy syndrome	0.00278	0.00652	CbGbCtD
Carbinoxamine—CYP3A4—Phenytoin—epilepsy syndrome	0.00267	0.00627	CbGbCtD
Carbinoxamine—CYP3A4—Propofol—epilepsy syndrome	0.00249	0.00585	CbGbCtD
Carbinoxamine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00238	0.00559	CbGbCtD
Carbinoxamine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00238	0.00559	CbGbCtD
Carbinoxamine—CYP3A4—Midazolam—epilepsy syndrome	0.00235	0.00551	CbGbCtD
Carbinoxamine—CYP3A4—Diazepam—epilepsy syndrome	0.00226	0.0053	CbGbCtD
Carbinoxamine—CYP3A4—Zonisamide—epilepsy syndrome	0.0022	0.00517	CbGbCtD
Carbinoxamine—CYP3A4—Valproic Acid—epilepsy syndrome	0.00178	0.00418	CbGbCtD
Carbinoxamine—CYP3A4—Topiramate—epilepsy syndrome	0.00161	0.00377	CbGbCtD
Carbinoxamine—Mitotane—CYP11A1—epilepsy syndrome	0.000281	0.108	CrCbGaD
Carbinoxamine—Doxylamine—CHRM1—epilepsy syndrome	0.000181	0.0698	CrCbGaD
Carbinoxamine—Orphenadrine—SCN9A—epilepsy syndrome	0.000153	0.0592	CrCbGaD
Carbinoxamine—Orphenadrine—SCN4A—epilepsy syndrome	0.000141	0.0544	CrCbGaD
Carbinoxamine—Dimetindene—CHRM2—epilepsy syndrome	0.000129	0.0498	CrCbGaD
Carbinoxamine—Brompheniramine—CHRM3—epilepsy syndrome	0.000109	0.0422	CrCbGaD
Carbinoxamine—Orphenadrine—SCN1A—epilepsy syndrome	0.000103	0.0398	CrCbGaD
Carbinoxamine—Brompheniramine—CHRM1—epilepsy syndrome	0.000102	0.0393	CrCbGaD
Carbinoxamine—Dyspepsia—Clonazepam—epilepsy syndrome	9.29e-05	0.000834	CcSEcCtD
Carbinoxamine—Somnolence—Oxcarbazepine—epilepsy syndrome	9.27e-05	0.000833	CcSEcCtD
Carbinoxamine—Nausea—Clobazam—epilepsy syndrome	9.27e-05	0.000832	CcSEcCtD
Carbinoxamine—Asthenia—Propofol—epilepsy syndrome	9.27e-05	0.000832	CcSEcCtD
Carbinoxamine—Tension—Valproic Acid—epilepsy syndrome	9.24e-05	0.00083	CcSEcCtD
Carbinoxamine—Dyspepsia—Phenytoin—epilepsy syndrome	9.23e-05	0.000829	CcSEcCtD
Carbinoxamine—Feeling abnormal—Felbamate—epilepsy syndrome	9.22e-05	0.000828	CcSEcCtD
Carbinoxamine—Anorexia—Lamotrigine—epilepsy syndrome	9.22e-05	0.000828	CcSEcCtD
Carbinoxamine—Dizziness—Acetazolamide—epilepsy syndrome	9.2e-05	0.000826	CcSEcCtD
Carbinoxamine—Urticaria—Diazepam—epilepsy syndrome	9.18e-05	0.000825	CcSEcCtD
Carbinoxamine—Sweating increased—Topiramate—epilepsy syndrome	9.18e-05	0.000825	CcSEcCtD
Carbinoxamine—Dyspepsia—Oxcarbazepine—epilepsy syndrome	9.18e-05	0.000824	CcSEcCtD
Carbinoxamine—Decreased appetite—Clonazepam—epilepsy syndrome	9.18e-05	0.000824	CcSEcCtD
Carbinoxamine—Nervousness—Valproic Acid—epilepsy syndrome	9.15e-05	0.000821	CcSEcCtD
Carbinoxamine—Tinnitus—Pregabalin—epilepsy syndrome	9.12e-05	0.000819	CcSEcCtD
Carbinoxamine—Decreased appetite—Phenytoin—epilepsy syndrome	9.11e-05	0.000818	CcSEcCtD
Carbinoxamine—Fatigue—Clonazepam—epilepsy syndrome	9.1e-05	0.000817	CcSEcCtD
Carbinoxamine—Asthenia—Midazolam—epilepsy syndrome	9.07e-05	0.000814	CcSEcCtD
Carbinoxamine—Decreased appetite—Oxcarbazepine—epilepsy syndrome	9.07e-05	0.000814	CcSEcCtD
Carbinoxamine—Insomnia—Carbamazepine—epilepsy syndrome	9.05e-05	0.000813	CcSEcCtD
Carbinoxamine—Fatigue—Phenytoin—epilepsy syndrome	9.04e-05	0.000812	CcSEcCtD
Carbinoxamine—Constipation—Clonazepam—epilepsy syndrome	9.03e-05	0.000811	CcSEcCtD
Carbinoxamine—Feeling abnormal—Zonisamide—epilepsy syndrome	9.02e-05	0.00081	CcSEcCtD
Carbinoxamine—Fatigue—Oxcarbazepine—epilepsy syndrome	8.99e-05	0.000807	CcSEcCtD
Carbinoxamine—Paraesthesia—Carbamazepine—epilepsy syndrome	8.99e-05	0.000807	CcSEcCtD
Carbinoxamine—Constipation—Phenytoin—epilepsy syndrome	8.97e-05	0.000805	CcSEcCtD
Carbinoxamine—Asthenia—Levetiracetam—epilepsy syndrome	8.95e-05	0.000804	CcSEcCtD
Carbinoxamine—Constipation—Oxcarbazepine—epilepsy syndrome	8.92e-05	0.000801	CcSEcCtD
Carbinoxamine—Somnolence—Carbamazepine—epilepsy syndrome	8.9e-05	0.000799	CcSEcCtD
Carbinoxamine—Urticaria—Felbamate—epilepsy syndrome	8.89e-05	0.000798	CcSEcCtD
Carbinoxamine—Vision blurred—Valproic Acid—epilepsy syndrome	8.87e-05	0.000797	CcSEcCtD
Carbinoxamine—Vomiting—Acetazolamide—epilepsy syndrome	8.84e-05	0.000794	CcSEcCtD
Carbinoxamine—Diarrhoea—Propofol—epilepsy syndrome	8.84e-05	0.000794	CcSEcCtD
Carbinoxamine—Tremor—Valproic Acid—epilepsy syndrome	8.82e-05	0.000792	CcSEcCtD
Carbinoxamine—Dyspepsia—Carbamazepine—epilepsy syndrome	8.81e-05	0.000791	CcSEcCtD
Carbinoxamine—Chills—Pregabalin—epilepsy syndrome	8.78e-05	0.000788	CcSEcCtD
Carbinoxamine—Insomnia—Lamotrigine—epilepsy syndrome	8.75e-05	0.000786	CcSEcCtD
Carbinoxamine—Headache—Acetazolamide—epilepsy syndrome	8.71e-05	0.000782	CcSEcCtD
Carbinoxamine—Pollakiuria—Topiramate—epilepsy syndrome	8.71e-05	0.000782	CcSEcCtD
Carbinoxamine—Urticaria—Zonisamide—epilepsy syndrome	8.7e-05	0.000781	CcSEcCtD
Carbinoxamine—Decreased appetite—Carbamazepine—epilepsy syndrome	8.7e-05	0.000781	CcSEcCtD
Carbinoxamine—Feeling abnormal—Clonazepam—epilepsy syndrome	8.7e-05	0.000781	CcSEcCtD
Carbinoxamine—Paraesthesia—Lamotrigine—epilepsy syndrome	8.68e-05	0.00078	CcSEcCtD
Carbinoxamine—Agitation—Valproic Acid—epilepsy syndrome	8.65e-05	0.000777	CcSEcCtD
Carbinoxamine—Asthenia—Fosphenytoin—epilepsy syndrome	8.64e-05	0.000776	CcSEcCtD
Carbinoxamine—Feeling abnormal—Phenytoin—epilepsy syndrome	8.64e-05	0.000776	CcSEcCtD
Carbinoxamine—Fatigue—Carbamazepine—epilepsy syndrome	8.63e-05	0.000775	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Topiramate—epilepsy syndrome	8.6e-05	0.000773	CcSEcCtD
Carbinoxamine—Somnolence—Lamotrigine—epilepsy syndrome	8.6e-05	0.000772	CcSEcCtD
Carbinoxamine—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	8.59e-05	0.000772	CcSEcCtD
Carbinoxamine—Constipation—Carbamazepine—epilepsy syndrome	8.56e-05	0.000769	CcSEcCtD
Carbinoxamine—Dizziness—Propofol—epilepsy syndrome	8.54e-05	0.000767	CcSEcCtD
Carbinoxamine—Diarrhoea—Levetiracetam—epilepsy syndrome	8.54e-05	0.000767	CcSEcCtD
Carbinoxamine—Dyspepsia—Lamotrigine—epilepsy syndrome	8.51e-05	0.000765	CcSEcCtD
Carbinoxamine—Vertigo—Valproic Acid—epilepsy syndrome	8.46e-05	0.00076	CcSEcCtD
Carbinoxamine—Asthenia—Vigabatrin—epilepsy syndrome	8.42e-05	0.000757	CcSEcCtD
Carbinoxamine—Decreased appetite—Lamotrigine—epilepsy syndrome	8.41e-05	0.000755	CcSEcCtD
Carbinoxamine—Urticaria—Clonazepam—epilepsy syndrome	8.38e-05	0.000753	CcSEcCtD
Carbinoxamine—Tinnitus—Gabapentin—epilepsy syndrome	8.36e-05	0.000751	CcSEcCtD
Carbinoxamine—Dizziness—Midazolam—epilepsy syndrome	8.36e-05	0.000751	CcSEcCtD
Carbinoxamine—Tension—Pregabalin—epilepsy syndrome	8.35e-05	0.00075	CcSEcCtD
Carbinoxamine—Fatigue—Lamotrigine—epilepsy syndrome	8.34e-05	0.000749	CcSEcCtD
Carbinoxamine—Urticaria—Phenytoin—epilepsy syndrome	8.33e-05	0.000748	CcSEcCtD
Carbinoxamine—Palpitations—Valproic Acid—epilepsy syndrome	8.32e-05	0.000747	CcSEcCtD
Carbinoxamine—Brompheniramine—CHRM2—epilepsy syndrome	8.31e-05	0.0321	CrCbGaD
Carbinoxamine—Asthenia—Diazepam—epilepsy syndrome	8.29e-05	0.000745	CcSEcCtD
Carbinoxamine—Urticaria—Oxcarbazepine—epilepsy syndrome	8.28e-05	0.000744	CcSEcCtD
Carbinoxamine—Constipation—Lamotrigine—epilepsy syndrome	8.27e-05	0.000743	CcSEcCtD
Carbinoxamine—Nervousness—Pregabalin—epilepsy syndrome	8.27e-05	0.000743	CcSEcCtD
Carbinoxamine—Nausea—Acetazolamide—epilepsy syndrome	8.26e-05	0.000742	CcSEcCtD
Carbinoxamine—Dizziness—Levetiracetam—epilepsy syndrome	8.25e-05	0.000741	CcSEcCtD
Carbinoxamine—Feeling abnormal—Carbamazepine—epilepsy syndrome	8.25e-05	0.000741	CcSEcCtD
Carbinoxamine—Diarrhoea—Fosphenytoin—epilepsy syndrome	8.24e-05	0.00074	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Topiramate—epilepsy syndrome	8.24e-05	0.00074	CcSEcCtD
Carbinoxamine—Vomiting—Propofol—epilepsy syndrome	8.21e-05	0.000738	CcSEcCtD
Carbinoxamine—Headache—Propofol—epilepsy syndrome	8.09e-05	0.000727	CcSEcCtD
Carbinoxamine—Chills—Gabapentin—epilepsy syndrome	8.05e-05	0.000723	CcSEcCtD
Carbinoxamine—Vomiting—Midazolam—epilepsy syndrome	8.04e-05	0.000722	CcSEcCtD
Carbinoxamine—Diarrhoea—Vigabatrin—epilepsy syndrome	8.03e-05	0.000721	CcSEcCtD
Carbinoxamine—Asthenia—Felbamate—epilepsy syndrome	8.03e-05	0.000721	CcSEcCtD
Carbinoxamine—Vision blurred—Pregabalin—epilepsy syndrome	8.02e-05	0.000721	CcSEcCtD
Carbinoxamine—Chlorprothixene—CHRM3—epilepsy syndrome	8.01e-05	0.031	CrCbGaD
Carbinoxamine—Tremor—Pregabalin—epilepsy syndrome	7.98e-05	0.000716	CcSEcCtD
Carbinoxamine—Feeling abnormal—Lamotrigine—epilepsy syndrome	7.97e-05	0.000716	CcSEcCtD
Carbinoxamine—Dizziness—Fosphenytoin—epilepsy syndrome	7.97e-05	0.000715	CcSEcCtD
Carbinoxamine—Urticaria—Carbamazepine—epilepsy syndrome	7.95e-05	0.000714	CcSEcCtD
Carbinoxamine—Vomiting—Levetiracetam—epilepsy syndrome	7.94e-05	0.000713	CcSEcCtD
Carbinoxamine—Headache—Midazolam—epilepsy syndrome	7.92e-05	0.000711	CcSEcCtD
Carbinoxamine—Diarrhoea—Diazepam—epilepsy syndrome	7.91e-05	0.00071	CcSEcCtD
Carbinoxamine—Asthenia—Zonisamide—epilepsy syndrome	7.86e-05	0.000706	CcSEcCtD
Carbinoxamine—Agranulocytosis—Topiramate—epilepsy syndrome	7.84e-05	0.000704	CcSEcCtD
Carbinoxamine—Agitation—Pregabalin—epilepsy syndrome	7.82e-05	0.000703	CcSEcCtD
Carbinoxamine—Headache—Levetiracetam—epilepsy syndrome	7.82e-05	0.000702	CcSEcCtD
Carbinoxamine—Dizziness—Vigabatrin—epilepsy syndrome	7.76e-05	0.000697	CcSEcCtD
Carbinoxamine—Confusional state—Valproic Acid—epilepsy syndrome	7.75e-05	0.000696	CcSEcCtD
Carbinoxamine—Urticaria—Lamotrigine—epilepsy syndrome	7.68e-05	0.00069	CcSEcCtD
Carbinoxamine—Nausea—Propofol—epilepsy syndrome	7.67e-05	0.000689	CcSEcCtD
Carbinoxamine—Tension—Gabapentin—epilepsy syndrome	7.66e-05	0.000688	CcSEcCtD
Carbinoxamine—Vomiting—Fosphenytoin—epilepsy syndrome	7.66e-05	0.000688	CcSEcCtD
Carbinoxamine—Diarrhoea—Felbamate—epilepsy syndrome	7.66e-05	0.000687	CcSEcCtD
Carbinoxamine—Vertigo—Pregabalin—epilepsy syndrome	7.65e-05	0.000687	CcSEcCtD
Carbinoxamine—Dizziness—Diazepam—epilepsy syndrome	7.64e-05	0.000687	CcSEcCtD
Carbinoxamine—Nervousness—Gabapentin—epilepsy syndrome	7.58e-05	0.000681	CcSEcCtD
Carbinoxamine—Asthenia—Clonazepam—epilepsy syndrome	7.57e-05	0.00068	CcSEcCtD
Carbinoxamine—Headache—Fosphenytoin—epilepsy syndrome	7.55e-05	0.000678	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Valproic Acid—epilepsy syndrome	7.53e-05	0.000676	CcSEcCtD
Carbinoxamine—Palpitations—Pregabalin—epilepsy syndrome	7.52e-05	0.000676	CcSEcCtD
Carbinoxamine—Asthenia—Phenytoin—epilepsy syndrome	7.52e-05	0.000676	CcSEcCtD
Carbinoxamine—Nausea—Midazolam—epilepsy syndrome	7.51e-05	0.000674	CcSEcCtD
Carbinoxamine—Tachycardia—Valproic Acid—epilepsy syndrome	7.5e-05	0.000674	CcSEcCtD
Carbinoxamine—Diarrhoea—Zonisamide—epilepsy syndrome	7.49e-05	0.000673	CcSEcCtD
Carbinoxamine—Asthenia—Oxcarbazepine—epilepsy syndrome	7.48e-05	0.000672	CcSEcCtD
Carbinoxamine—Chlorprothixene—CHRM1—epilepsy syndrome	7.47e-05	0.0289	CrCbGaD
Carbinoxamine—Vomiting—Vigabatrin—epilepsy syndrome	7.47e-05	0.00067	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	7.43e-05	0.000667	CcSEcCtD
Carbinoxamine—Nausea—Levetiracetam—epilepsy syndrome	7.41e-05	0.000666	CcSEcCtD
Carbinoxamine—Dizziness—Felbamate—epilepsy syndrome	7.4e-05	0.000664	CcSEcCtD
Carbinoxamine—Convulsion—Pregabalin—epilepsy syndrome	7.38e-05	0.000662	CcSEcCtD
Carbinoxamine—Vision blurred—Gabapentin—epilepsy syndrome	7.36e-05	0.000661	CcSEcCtD
Carbinoxamine—Headache—Vigabatrin—epilepsy syndrome	7.36e-05	0.000661	CcSEcCtD
Carbinoxamine—Vomiting—Diazepam—epilepsy syndrome	7.35e-05	0.00066	CcSEcCtD
Carbinoxamine—Anorexia—Valproic Acid—epilepsy syndrome	7.33e-05	0.000658	CcSEcCtD
Carbinoxamine—Tremor—Gabapentin—epilepsy syndrome	7.31e-05	0.000657	CcSEcCtD
Carbinoxamine—Dizziness—Zonisamide—epilepsy syndrome	7.24e-05	0.00065	CcSEcCtD
Carbinoxamine—Headache—Diazepam—epilepsy syndrome	7.24e-05	0.00065	CcSEcCtD
Carbinoxamine—Diarrhoea—Clonazepam—epilepsy syndrome	7.22e-05	0.000649	CcSEcCtD
Carbinoxamine—Hypotension—Valproic Acid—epilepsy syndrome	7.18e-05	0.000645	CcSEcCtD
Carbinoxamine—Asthenia—Carbamazepine—epilepsy syndrome	7.18e-05	0.000645	CcSEcCtD
Carbinoxamine—Agitation—Gabapentin—epilepsy syndrome	7.17e-05	0.000644	CcSEcCtD
Carbinoxamine—Diarrhoea—Phenytoin—epilepsy syndrome	7.17e-05	0.000644	CcSEcCtD
Carbinoxamine—Nausea—Fosphenytoin—epilepsy syndrome	7.16e-05	0.000643	CcSEcCtD
Carbinoxamine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	7.14e-05	0.000641	CcSEcCtD
Carbinoxamine—Vomiting—Felbamate—epilepsy syndrome	7.11e-05	0.000639	CcSEcCtD
Carbinoxamine—Tinnitus—Topiramate—epilepsy syndrome	7.03e-05	0.000632	CcSEcCtD
Carbinoxamine—Vertigo—Gabapentin—epilepsy syndrome	7.01e-05	0.00063	CcSEcCtD
Carbinoxamine—Headache—Felbamate—epilepsy syndrome	7.01e-05	0.000629	CcSEcCtD
Carbinoxamine—Confusional state—Pregabalin—epilepsy syndrome	7.01e-05	0.000629	CcSEcCtD
Carbinoxamine—Dizziness—Clonazepam—epilepsy syndrome	6.98e-05	0.000627	CcSEcCtD
Carbinoxamine—Nausea—Vigabatrin—epilepsy syndrome	6.97e-05	0.000626	CcSEcCtD
Carbinoxamine—Vomiting—Zonisamide—epilepsy syndrome	6.96e-05	0.000625	CcSEcCtD
Carbinoxamine—Insomnia—Valproic Acid—epilepsy syndrome	6.95e-05	0.000624	CcSEcCtD
Carbinoxamine—Mepyramine—CYP2D6—epilepsy syndrome	6.94e-05	0.0268	CrCbGaD
Carbinoxamine—Asthenia—Lamotrigine—epilepsy syndrome	6.94e-05	0.000623	CcSEcCtD
Carbinoxamine—Dizziness—Phenytoin—epilepsy syndrome	6.93e-05	0.000623	CcSEcCtD
Carbinoxamine—Paraesthesia—Valproic Acid—epilepsy syndrome	6.9e-05	0.00062	CcSEcCtD
Carbinoxamine—Palpitations—Gabapentin—epilepsy syndrome	6.9e-05	0.00062	CcSEcCtD
Carbinoxamine—Dizziness—Oxcarbazepine—epilepsy syndrome	6.9e-05	0.000619	CcSEcCtD
Carbinoxamine—Nausea—Diazepam—epilepsy syndrome	6.87e-05	0.000617	CcSEcCtD
Carbinoxamine—Headache—Zonisamide—epilepsy syndrome	6.86e-05	0.000616	CcSEcCtD
Carbinoxamine—Diarrhoea—Carbamazepine—epilepsy syndrome	6.85e-05	0.000615	CcSEcCtD
Carbinoxamine—Somnolence—Valproic Acid—epilepsy syndrome	6.83e-05	0.000614	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Pregabalin—epilepsy syndrome	6.8e-05	0.000611	CcSEcCtD
Carbinoxamine—Tachycardia—Pregabalin—epilepsy syndrome	6.78e-05	0.000609	CcSEcCtD
Carbinoxamine—Chills—Topiramate—epilepsy syndrome	6.77e-05	0.000608	CcSEcCtD
Carbinoxamine—Dyspepsia—Valproic Acid—epilepsy syndrome	6.77e-05	0.000608	CcSEcCtD
Carbinoxamine—Convulsion—Gabapentin—epilepsy syndrome	6.76e-05	0.000607	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Pregabalin—epilepsy syndrome	6.72e-05	0.000603	CcSEcCtD
Carbinoxamine—Vomiting—Clonazepam—epilepsy syndrome	6.71e-05	0.000603	CcSEcCtD
Carbinoxamine—Decreased appetite—Valproic Acid—epilepsy syndrome	6.68e-05	0.0006	CcSEcCtD
Carbinoxamine—Vomiting—Phenytoin—epilepsy syndrome	6.67e-05	0.000599	CcSEcCtD
Carbinoxamine—Nausea—Felbamate—epilepsy syndrome	6.65e-05	0.000597	CcSEcCtD
Carbinoxamine—Vomiting—Oxcarbazepine—epilepsy syndrome	6.63e-05	0.000595	CcSEcCtD
Carbinoxamine—Fatigue—Valproic Acid—epilepsy syndrome	6.63e-05	0.000595	CcSEcCtD
Carbinoxamine—Anorexia—Pregabalin—epilepsy syndrome	6.62e-05	0.000595	CcSEcCtD
Carbinoxamine—Dizziness—Carbamazepine—epilepsy syndrome	6.62e-05	0.000594	CcSEcCtD
Carbinoxamine—Diarrhoea—Lamotrigine—epilepsy syndrome	6.62e-05	0.000594	CcSEcCtD
Carbinoxamine—Headache—Clonazepam—epilepsy syndrome	6.61e-05	0.000594	CcSEcCtD
Carbinoxamine—Constipation—Valproic Acid—epilepsy syndrome	6.57e-05	0.00059	CcSEcCtD
Carbinoxamine—Headache—Phenytoin—epilepsy syndrome	6.57e-05	0.00059	CcSEcCtD
Carbinoxamine—Headache—Oxcarbazepine—epilepsy syndrome	6.53e-05	0.000587	CcSEcCtD
Carbinoxamine—Nausea—Zonisamide—epilepsy syndrome	6.51e-05	0.000584	CcSEcCtD
Carbinoxamine—Hypotension—Pregabalin—epilepsy syndrome	6.49e-05	0.000583	CcSEcCtD
Carbinoxamine—Tension—Topiramate—epilepsy syndrome	6.45e-05	0.000579	CcSEcCtD
Carbinoxamine—Confusional state—Gabapentin—epilepsy syndrome	6.42e-05	0.000577	CcSEcCtD
Carbinoxamine—Tripelennamine—CYP2D6—epilepsy syndrome	6.42e-05	0.0248	CrCbGaD
Carbinoxamine—Dizziness—Lamotrigine—epilepsy syndrome	6.4e-05	0.000574	CcSEcCtD
Carbinoxamine—Nervousness—Topiramate—epilepsy syndrome	6.38e-05	0.000573	CcSEcCtD
Carbinoxamine—Vomiting—Carbamazepine—epilepsy syndrome	6.36e-05	0.000571	CcSEcCtD
Carbinoxamine—Feeling abnormal—Valproic Acid—epilepsy syndrome	6.33e-05	0.000569	CcSEcCtD
Carbinoxamine—Insomnia—Pregabalin—epilepsy syndrome	6.28e-05	0.000564	CcSEcCtD
Carbinoxamine—Nausea—Clonazepam—epilepsy syndrome	6.27e-05	0.000563	CcSEcCtD
Carbinoxamine—Headache—Carbamazepine—epilepsy syndrome	6.27e-05	0.000563	CcSEcCtD
Carbinoxamine—Paraesthesia—Pregabalin—epilepsy syndrome	6.24e-05	0.00056	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Gabapentin—epilepsy syndrome	6.24e-05	0.00056	CcSEcCtD
Carbinoxamine—Nausea—Phenytoin—epilepsy syndrome	6.23e-05	0.000559	CcSEcCtD
Carbinoxamine—Tachycardia—Gabapentin—epilepsy syndrome	6.22e-05	0.000558	CcSEcCtD
Carbinoxamine—Nausea—Oxcarbazepine—epilepsy syndrome	6.19e-05	0.000556	CcSEcCtD
Carbinoxamine—Vision blurred—Topiramate—epilepsy syndrome	6.19e-05	0.000556	CcSEcCtD
Carbinoxamine—Somnolence—Pregabalin—epilepsy syndrome	6.18e-05	0.000555	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Gabapentin—epilepsy syndrome	6.16e-05	0.000553	CcSEcCtD
Carbinoxamine—Tremor—Topiramate—epilepsy syndrome	6.15e-05	0.000553	CcSEcCtD
Carbinoxamine—Vomiting—Lamotrigine—epilepsy syndrome	6.15e-05	0.000552	CcSEcCtD
Carbinoxamine—Urticaria—Valproic Acid—epilepsy syndrome	6.11e-05	0.000548	CcSEcCtD
Carbinoxamine—Chlorprothixene—CHRM2—epilepsy syndrome	6.1e-05	0.0236	CrCbGaD
Carbinoxamine—Anorexia—Gabapentin—epilepsy syndrome	6.07e-05	0.000545	CcSEcCtD
Carbinoxamine—Headache—Lamotrigine—epilepsy syndrome	6.06e-05	0.000544	CcSEcCtD
Carbinoxamine—Decreased appetite—Pregabalin—epilepsy syndrome	6.04e-05	0.000542	CcSEcCtD
Carbinoxamine—Agitation—Topiramate—epilepsy syndrome	6.04e-05	0.000542	CcSEcCtD
Carbinoxamine—Fatigue—Pregabalin—epilepsy syndrome	5.99e-05	0.000538	CcSEcCtD
Carbinoxamine—Hypotension—Gabapentin—epilepsy syndrome	5.95e-05	0.000535	CcSEcCtD
Carbinoxamine—Nausea—Carbamazepine—epilepsy syndrome	5.94e-05	0.000534	CcSEcCtD
Carbinoxamine—Constipation—Pregabalin—epilepsy syndrome	5.94e-05	0.000534	CcSEcCtD
Carbinoxamine—Vertigo—Topiramate—epilepsy syndrome	5.9e-05	0.00053	CcSEcCtD
Carbinoxamine—Palpitations—Topiramate—epilepsy syndrome	5.8e-05	0.000521	CcSEcCtD
Carbinoxamine—Insomnia—Gabapentin—epilepsy syndrome	5.76e-05	0.000518	CcSEcCtD
Carbinoxamine—Nausea—Lamotrigine—epilepsy syndrome	5.74e-05	0.000516	CcSEcCtD
Carbinoxamine—Feeling abnormal—Pregabalin—epilepsy syndrome	5.73e-05	0.000514	CcSEcCtD
Carbinoxamine—Paraesthesia—Gabapentin—epilepsy syndrome	5.72e-05	0.000514	CcSEcCtD
Carbinoxamine—Convulsion—Topiramate—epilepsy syndrome	5.69e-05	0.000511	CcSEcCtD
Carbinoxamine—Somnolence—Gabapentin—epilepsy syndrome	5.66e-05	0.000509	CcSEcCtD
Carbinoxamine—Dyspepsia—Gabapentin—epilepsy syndrome	5.61e-05	0.000504	CcSEcCtD
Carbinoxamine—Decreased appetite—Gabapentin—epilepsy syndrome	5.54e-05	0.000497	CcSEcCtD
Carbinoxamine—Diphenhydramine—CHRM2—epilepsy syndrome	5.54e-05	0.0214	CrCbGaD
Carbinoxamine—Chlorpromazine—CHRM3—epilepsy syndrome	5.52e-05	0.0213	CrCbGaD
Carbinoxamine—Urticaria—Pregabalin—epilepsy syndrome	5.52e-05	0.000496	CcSEcCtD
Carbinoxamine—Asthenia—Valproic Acid—epilepsy syndrome	5.51e-05	0.000495	CcSEcCtD
Carbinoxamine—Fatigue—Gabapentin—epilepsy syndrome	5.49e-05	0.000493	CcSEcCtD
Carbinoxamine—Constipation—Gabapentin—epilepsy syndrome	5.45e-05	0.000489	CcSEcCtD
Carbinoxamine—Confusional state—Topiramate—epilepsy syndrome	5.4e-05	0.000485	CcSEcCtD
Carbinoxamine—Chlorphenamine—SLC6A4—epilepsy syndrome	5.31e-05	0.0205	CrCbGaD
Carbinoxamine—Diarrhoea—Valproic Acid—epilepsy syndrome	5.26e-05	0.000472	CcSEcCtD
Carbinoxamine—Feeling abnormal—Gabapentin—epilepsy syndrome	5.25e-05	0.000472	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Topiramate—epilepsy syndrome	5.25e-05	0.000471	CcSEcCtD
Carbinoxamine—Orphenadrine—CHRM2—epilepsy syndrome	5.24e-05	0.0202	CrCbGaD
Carbinoxamine—Tachycardia—Topiramate—epilepsy syndrome	5.23e-05	0.00047	CcSEcCtD
Carbinoxamine—Clomipramine—ADRA2A—epilepsy syndrome	5.23e-05	0.0202	CrCbGaD
Carbinoxamine—Hyperhidrosis—Topiramate—epilepsy syndrome	5.18e-05	0.000465	CcSEcCtD
Carbinoxamine—Chlorpromazine—CHRM1—epilepsy syndrome	5.15e-05	0.0199	CrCbGaD
Carbinoxamine—Brompheniramine—CYP2C19—epilepsy syndrome	5.13e-05	0.0198	CrCbGaD
Carbinoxamine—Anorexia—Topiramate—epilepsy syndrome	5.11e-05	0.000459	CcSEcCtD
Carbinoxamine—Dizziness—Valproic Acid—epilepsy syndrome	5.08e-05	0.000456	CcSEcCtD
Carbinoxamine—Urticaria—Gabapentin—epilepsy syndrome	5.06e-05	0.000455	CcSEcCtD
Carbinoxamine—Hypotension—Topiramate—epilepsy syndrome	5.01e-05	0.00045	CcSEcCtD
Carbinoxamine—Asthenia—Pregabalin—epilepsy syndrome	4.99e-05	0.000448	CcSEcCtD
Carbinoxamine—Vomiting—Valproic Acid—epilepsy syndrome	4.89e-05	0.000439	CcSEcCtD
Carbinoxamine—Insomnia—Topiramate—epilepsy syndrome	4.85e-05	0.000435	CcSEcCtD
Carbinoxamine—Headache—Valproic Acid—epilepsy syndrome	4.81e-05	0.000432	CcSEcCtD
Carbinoxamine—Paraesthesia—Topiramate—epilepsy syndrome	4.81e-05	0.000432	CcSEcCtD
Carbinoxamine—Somnolence—Topiramate—epilepsy syndrome	4.77e-05	0.000428	CcSEcCtD
Carbinoxamine—Diarrhoea—Pregabalin—epilepsy syndrome	4.75e-05	0.000427	CcSEcCtD
Carbinoxamine—Dyspepsia—Topiramate—epilepsy syndrome	4.72e-05	0.000424	CcSEcCtD
Carbinoxamine—Decreased appetite—Topiramate—epilepsy syndrome	4.66e-05	0.000418	CcSEcCtD
Carbinoxamine—Fatigue—Topiramate—epilepsy syndrome	4.62e-05	0.000415	CcSEcCtD
Carbinoxamine—Dizziness—Pregabalin—epilepsy syndrome	4.59e-05	0.000413	CcSEcCtD
Carbinoxamine—Constipation—Topiramate—epilepsy syndrome	4.58e-05	0.000412	CcSEcCtD
Carbinoxamine—Asthenia—Gabapentin—epilepsy syndrome	4.57e-05	0.000411	CcSEcCtD
Carbinoxamine—Nausea—Valproic Acid—epilepsy syndrome	4.57e-05	0.00041	CcSEcCtD
Carbinoxamine—Vomiting—Pregabalin—epilepsy syndrome	4.42e-05	0.000397	CcSEcCtD
Carbinoxamine—Feeling abnormal—Topiramate—epilepsy syndrome	4.42e-05	0.000397	CcSEcCtD
Carbinoxamine—Diarrhoea—Gabapentin—epilepsy syndrome	4.36e-05	0.000391	CcSEcCtD
Carbinoxamine—Headache—Pregabalin—epilepsy syndrome	4.35e-05	0.000391	CcSEcCtD
Carbinoxamine—Urticaria—Topiramate—epilepsy syndrome	4.26e-05	0.000382	CcSEcCtD
Carbinoxamine—Dizziness—Gabapentin—epilepsy syndrome	4.21e-05	0.000378	CcSEcCtD
Carbinoxamine—Chlorpromazine—CHRM2—epilepsy syndrome	4.2e-05	0.0162	CrCbGaD
Carbinoxamine—Chlorpromazine—HTR7—epilepsy syndrome	4.18e-05	0.0162	CrCbGaD
Carbinoxamine—Nausea—Pregabalin—epilepsy syndrome	4.13e-05	0.000371	CcSEcCtD
Carbinoxamine—Vomiting—Gabapentin—epilepsy syndrome	4.05e-05	0.000364	CcSEcCtD
Carbinoxamine—Headache—Gabapentin—epilepsy syndrome	3.99e-05	0.000358	CcSEcCtD
Carbinoxamine—Clomipramine—SLC6A4—epilepsy syndrome	3.99e-05	0.0154	CrCbGaD
Carbinoxamine—Asthenia—Topiramate—epilepsy syndrome	3.85e-05	0.000345	CcSEcCtD
Carbinoxamine—Brompheniramine—CYP2D6—epilepsy syndrome	3.8e-05	0.0147	CrCbGaD
Carbinoxamine—Nausea—Gabapentin—epilepsy syndrome	3.78e-05	0.00034	CcSEcCtD
Carbinoxamine—Clomipramine—CYP2C19—epilepsy syndrome	3.78e-05	0.0146	CrCbGaD
Carbinoxamine—Chlorphenamine—CYP2D6—epilepsy syndrome	3.73e-05	0.0144	CrCbGaD
Carbinoxamine—Diarrhoea—Topiramate—epilepsy syndrome	3.67e-05	0.000329	CcSEcCtD
Carbinoxamine—Chlorpromazine—ADRA2A—epilepsy syndrome	3.59e-05	0.0139	CrCbGaD
Carbinoxamine—Dizziness—Topiramate—epilepsy syndrome	3.54e-05	0.000318	CcSEcCtD
Carbinoxamine—Chlorpromazine—BCHE—epilepsy syndrome	3.51e-05	0.0135	CrCbGaD
Carbinoxamine—Diphenhydramine—CYP2C19—epilepsy syndrome	3.42e-05	0.0132	CrCbGaD
Carbinoxamine—Vomiting—Topiramate—epilepsy syndrome	3.41e-05	0.000306	CcSEcCtD
Carbinoxamine—Headache—Topiramate—epilepsy syndrome	3.36e-05	0.000302	CcSEcCtD
Carbinoxamine—Nausea—Topiramate—epilepsy syndrome	3.18e-05	0.000286	CcSEcCtD
Carbinoxamine—Clomipramine—HTR2A—epilepsy syndrome	3.07e-05	0.0118	CrCbGaD
Carbinoxamine—Chlorprothixene—HTR2A—epilepsy syndrome	3.05e-05	0.0118	CrCbGaD
Carbinoxamine—Clomipramine—CYP2D6—epilepsy syndrome	2.8e-05	0.0108	CrCbGaD
Carbinoxamine—Diphenhydramine—CYP2D6—epilepsy syndrome	2.53e-05	0.00979	CrCbGaD
Carbinoxamine—Chlorpromazine—HTR2A—epilepsy syndrome	2.1e-05	0.00813	CrCbGaD
Carbinoxamine—Clomipramine—ALB—epilepsy syndrome	2.1e-05	0.00811	CrCbGaD
Carbinoxamine—Clomipramine—ABCB1—epilepsy syndrome	2e-05	0.00774	CrCbGaD
Carbinoxamine—Chlorprothixene—ABCB1—epilepsy syndrome	1.99e-05	0.0077	CrCbGaD
Carbinoxamine—Chlorpromazine—CYP2D6—epilepsy syndrome	1.92e-05	0.00743	CrCbGaD
Carbinoxamine—Chlorpromazine—ALB—epilepsy syndrome	1.44e-05	0.00556	CrCbGaD
Carbinoxamine—Chlorpromazine—ABCB1—epilepsy syndrome	1.37e-05	0.00531	CrCbGaD
Carbinoxamine—CYP3A4—Metabolism—PFKL—epilepsy syndrome	5.23e-06	0.000194	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	5.23e-06	0.000194	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	5.23e-06	0.000194	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	5.23e-06	0.000194	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ABCG2—epilepsy syndrome	5.14e-06	0.00019	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—CCR5—epilepsy syndrome	5.14e-06	0.00019	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.06e-06	0.000187	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ABCG2—epilepsy syndrome	5.04e-06	0.000186	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CCR3—epilepsy syndrome	5.03e-06	0.000186	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—HTR2A—epilepsy syndrome	5.03e-06	0.000186	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CYP2C19—epilepsy syndrome	5.01e-06	0.000186	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	5e-06	0.000185	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CYP11A1—epilepsy syndrome	4.98e-06	0.000184	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.98e-06	0.000184	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	4.95e-06	0.000183	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CYP2C19—epilepsy syndrome	4.91e-06	0.000182	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NPY—epilepsy syndrome	4.9e-06	0.000182	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ATP2A2—epilepsy syndrome	4.9e-06	0.000182	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CYP11A1—epilepsy syndrome	4.88e-06	0.000181	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.87e-06	0.00018	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—AQP1—epilepsy syndrome	4.85e-06	0.00018	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—AQP1—epilepsy syndrome	4.81e-06	0.000178	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—UPB1—epilepsy syndrome	4.79e-06	0.000177	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NEU1—epilepsy syndrome	4.79e-06	0.000177	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ATIC—epilepsy syndrome	4.79e-06	0.000177	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—AGT—epilepsy syndrome	4.77e-06	0.000177	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	4.77e-06	0.000176	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	4.77e-06	0.000176	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CCL3—epilepsy syndrome	4.73e-06	0.000175	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CRH—epilepsy syndrome	4.73e-06	0.000175	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CXCL2—epilepsy syndrome	4.73e-06	0.000175	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—OXT—epilepsy syndrome	4.73e-06	0.000175	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HSPB1—epilepsy syndrome	4.73e-06	0.000175	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—CCR5—epilepsy syndrome	4.67e-06	0.000173	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.62e-06	0.000171	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	4.61e-06	0.000171	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—HTR2A—epilepsy syndrome	4.57e-06	0.000169	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CYP2D6—epilepsy syndrome	4.5e-06	0.000166	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GBE1—epilepsy syndrome	4.45e-06	0.000165	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	4.45e-06	0.000165	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.44e-06	0.000164	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—PRKCB—epilepsy syndrome	4.41e-06	0.000163	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CYP2D6—epilepsy syndrome	4.4e-06	0.000163	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PTK2B—epilepsy syndrome	4.4e-06	0.000163	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TSC1—epilepsy syndrome	4.4e-06	0.000163	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	4.39e-06	0.000162	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	4.39e-06	0.000162	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	4.36e-06	0.000161	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.35e-06	0.000161	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	4.35e-06	0.000161	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	4.35e-06	0.000161	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—AGT—epilepsy syndrome	4.33e-06	0.00016	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ADRA2A—epilepsy syndrome	4.28e-06	0.000158	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CCR2—epilepsy syndrome	4.28e-06	0.000158	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SST—epilepsy syndrome	4.28e-06	0.000158	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NTRK2—epilepsy syndrome	4.28e-06	0.000158	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—BCHE—epilepsy syndrome	4.26e-06	0.000158	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	4.24e-06	0.000157	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—DUSP6—epilepsy syndrome	4.24e-06	0.000157	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	4.22e-06	0.000156	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ADRA2A—epilepsy syndrome	4.19e-06	0.000155	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.19e-06	0.000155	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ADRA2A—epilepsy syndrome	4.19e-06	0.000155	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	4.18e-06	0.000155	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—BCHE—epilepsy syndrome	4.17e-06	0.000155	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PLAT—epilepsy syndrome	4.17e-06	0.000154	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.07e-06	0.000151	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—SLC2A1—epilepsy syndrome	4.07e-06	0.000151	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.05e-06	0.00015	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CXCL12—epilepsy syndrome	4.02e-06	0.000149	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—BDKRB2—epilepsy syndrome	4.02e-06	0.000149	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PLCB1—epilepsy syndrome	4.02e-06	0.000149	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—POMC—epilepsy syndrome	4.02e-06	0.000149	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—TH—epilepsy syndrome	4.01e-06	0.000148	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—PRKCB—epilepsy syndrome	4e-06	0.000148	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—IL6ST—epilepsy syndrome	3.99e-06	0.000148	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—SLC2A1—epilepsy syndrome	3.98e-06	0.000147	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.97e-06	0.000147	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	3.97e-06	0.000147	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	3.97e-06	0.000147	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—JUNB—epilepsy syndrome	3.95e-06	0.000146	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CNR1—epilepsy syndrome	3.95e-06	0.000146	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PLCB1—epilepsy syndrome	3.94e-06	0.000146	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PLCB1—epilepsy syndrome	3.93e-06	0.000146	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—TH—epilepsy syndrome	3.93e-06	0.000145	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	3.89e-06	0.000144	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HTR7—epilepsy syndrome	3.85e-06	0.000143	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.82e-06	0.000141	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	3.81e-06	0.000141	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	3.78e-06	0.00014	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	3.78e-06	0.00014	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	3.76e-06	0.000139	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HBEGF—epilepsy syndrome	3.74e-06	0.000138	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.74e-06	0.000138	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	3.7e-06	0.000137	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AKT3—epilepsy syndrome	3.67e-06	0.000136	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—POMC—epilepsy syndrome	3.65e-06	0.000135	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	3.63e-06	0.000134	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	3.62e-06	0.000134	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—BCHE—epilepsy syndrome	3.61e-06	0.000134	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ADAM10—epilepsy syndrome	3.59e-06	0.000133	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	3.58e-06	0.000132	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—CCL2—epilepsy syndrome	3.57e-06	0.000132	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	3.56e-06	0.000132	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	3.54e-06	0.000131	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3.49e-06	0.000129	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	3.48e-06	0.000129	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	3.46e-06	0.000128	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	3.45e-06	0.000128	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	3.44e-06	0.000127	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	3.43e-06	0.000127	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.41e-06	0.000126	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.41e-06	0.000126	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	3.41e-06	0.000126	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	3.4e-06	0.000126	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—TH—epilepsy syndrome	3.39e-06	0.000126	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—S100B—epilepsy syndrome	3.39e-06	0.000125	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SOCS3—epilepsy syndrome	3.36e-06	0.000124	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CDC42—epilepsy syndrome	3.35e-06	0.000124	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	3.34e-06	0.000124	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.34e-06	0.000124	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CAT—epilepsy syndrome	3.3e-06	0.000122	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	3.28e-06	0.000121	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.27e-06	0.000121	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AVP—epilepsy syndrome	3.24e-06	0.00012	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	3.23e-06	0.00012	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CAT—epilepsy syndrome	3.23e-06	0.00012	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—BCHE—epilepsy syndrome	3.22e-06	0.000119	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	3.21e-06	0.000119	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.17e-06	0.000117	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	3.14e-06	0.000116	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.11e-06	0.000115	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	3.1e-06	0.000115	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	3.07e-06	0.000114	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HES1—epilepsy syndrome	3.07e-06	0.000113	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	3.04e-06	0.000112	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—TH—epilepsy syndrome	3.03e-06	0.000112	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—GPX1—epilepsy syndrome	2.98e-06	0.00011	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FYN—epilepsy syndrome	2.98e-06	0.00011	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.98e-06	0.00011	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	2.98e-06	0.00011	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	2.97e-06	0.00011	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	2.97e-06	0.00011	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	2.96e-06	0.00011	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	2.95e-06	0.000109	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—BCHE—epilepsy syndrome	2.94e-06	0.000109	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GPX1—epilepsy syndrome	2.92e-06	0.000108	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.87e-06	0.000106	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.87e-06	0.000106	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	2.87e-06	0.000106	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NGF—epilepsy syndrome	2.83e-06	0.000105	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	2.83e-06	0.000105	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	2.83e-06	0.000105	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	2.8e-06	0.000104	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	2.8e-06	0.000103	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CAT—epilepsy syndrome	2.79e-06	0.000103	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—TH—epilepsy syndrome	2.79e-06	0.000103	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	2.77e-06	0.000103	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—TH—epilepsy syndrome	2.76e-06	0.000102	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	2.76e-06	0.000102	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.72e-06	0.000101	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	2.72e-06	0.000101	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	2.7e-06	9.99e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—AGT—epilepsy syndrome	2.62e-06	9.69e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—APOE—epilepsy syndrome	2.56e-06	9.49e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—AGT—epilepsy syndrome	2.56e-06	9.49e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	2.56e-06	9.49e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AGT—epilepsy syndrome	2.56e-06	9.48e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	2.53e-06	9.36e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GPX1—epilepsy syndrome	2.53e-06	9.35e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—APOE—epilepsy syndrome	2.51e-06	9.3e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—APOE—epilepsy syndrome	2.51e-06	9.28e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CAT—epilepsy syndrome	2.49e-06	9.23e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—KDR—epilepsy syndrome	2.46e-06	9.1e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	2.43e-06	8.98e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	2.37e-06	8.76e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	2.36e-06	8.72e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.34e-06	8.65e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.32e-06	8.6e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	2.3e-06	8.53e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.29e-06	8.49e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.28e-06	8.43e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CAT—epilepsy syndrome	2.27e-06	8.42e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.26e-06	8.38e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GPX1—epilepsy syndrome	2.26e-06	8.35e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.23e-06	8.26e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—AGT—epilepsy syndrome	2.22e-06	8.2e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	2.21e-06	8.19e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—POMC—epilepsy syndrome	2.2e-06	8.15e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—APOE—epilepsy syndrome	2.17e-06	8.04e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—POMC—epilepsy syndrome	2.16e-06	7.99e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—POMC—epilepsy syndrome	2.15e-06	7.98e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	2.11e-06	7.8e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.07e-06	7.68e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GPX1—epilepsy syndrome	2.06e-06	7.61e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.04e-06	7.56e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ALB—epilepsy syndrome	2.01e-06	7.43e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—AGT—epilepsy syndrome	1.98e-06	7.32e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ALB—epilepsy syndrome	1.97e-06	7.28e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.95e-06	7.2e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.94e-06	7.17e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.94e-06	7.17e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	1.91e-06	7.05e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—POMC—epilepsy syndrome	1.86e-06	6.9e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.85e-06	6.84e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.83e-06	6.76e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—TH—epilepsy syndrome	1.82e-06	6.74e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.82e-06	6.73e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.8e-06	6.67e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.78e-06	6.6e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—RELA—epilepsy syndrome	1.77e-06	6.55e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.77e-06	6.54e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	1.76e-06	6.5e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	1.73e-06	6.42e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	1.72e-06	6.37e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ALB—epilepsy syndrome	1.7e-06	6.29e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.66e-06	6.16e-05	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.61e-06	5.96e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	1.6e-06	5.91e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—JUN—epilepsy syndrome	1.55e-06	5.74e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.53e-06	5.67e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.52e-06	5.63e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.52e-06	5.62e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.52e-06	5.62e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	1.51e-06	5.58e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.5e-06	5.55e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	1.49e-06	5.51e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	1.46e-06	5.41e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.46e-06	5.4e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.4e-06	5.17e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SRC—epilepsy syndrome	1.39e-06	5.15e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.38e-06	5.12e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.36e-06	5.02e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	1.35e-06	5.01e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.33e-06	4.91e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.22e-06	4.52e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.21e-06	4.48e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.19e-06	4.4e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.17e-06	4.31e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—POMC—epilepsy syndrome	1e-06	3.71e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALB—epilepsy syndrome	9.13e-07	3.38e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—AKT1—epilepsy syndrome	8.83e-07	3.27e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—AKT1—epilepsy syndrome	8.65e-07	3.2e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	8.64e-07	3.2e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	7.98e-07	2.96e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—AKT1—epilepsy syndrome	7.48e-07	2.77e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—AKT1—epilepsy syndrome	6.67e-07	2.47e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	6.14e-07	2.27e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—AKT1—epilepsy syndrome	6.08e-07	2.25e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.01e-07	1.49e-05	CbGpPWpGaD
